The role of venom proteomics and single-domain antibodies for antivenoms: Progress in snake envenoming treatment

Anna Carolina Machado Marinho,Alexander Chapeaurouge,Brunheld Maia Dutra,Barbara Cibelle S. F. Quintela,Soraya S. Pereira,Carla Freire C. Fernandes
DOI: https://doi.org/10.1016/j.drudis.2024.103967
IF: 8.369
2024-04-01
Drug Discovery Today
Abstract:Single-domain antibodies (sdAbs) hold promise for developing new biopharmaceuticals to treat neglected tropical diseases (NTDs), including snakebites, which are severe and occur frequently. In addition, limitations of conventional snakebite treatments, especially in terms of local action, and the global antivenom crisis incentivize the use of this biotechnological tool to design next-generation snakebite antivenoms. Conventional antivenoms for snakebite treatment are usually composed of...
pharmacology & pharmacy
What problem does this paper attempt to address?